Savara Share Price

Savara Share Price

NASDAQ: SVRA | Small Cap | Healthcare
$4.25
-$0.95 (-18.27%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Savara Stock Performance

Open
$4.18
Prev. Close
$5.20
Circuit Range
N/A
Day Range
$4.01 - $4.52
Year Range
$4.01 - $7.00
Volume
12,41,135
Average Traded
$4.35

Savara Share Price Today

As of 21 November 2026, Savara Inc.'s share price is $4.25. The stock opened at $4.18, compared to its previous close of $5.20. During today's trading session, Savara Inc.'s share price traded between $4.01 and $4.52, with an average price of $4.26. Over the past 52 weeks, the stock has recorded a high of $7.00 and a low of $4.01. In terms of performance, Savara Inc.'s share price has declined by 18.27% over the last six months and is down 32.32% on a year-on-year basis.

Savara Share Price Chart

Line chart of the Savara price trend over the selected period. The price fell overall, ranging from 4.21 to 4.50, ending at 4.25.
$4.01$4.52
L
Show Current Price
H

Savara Stock Fundamentals & Key Indicators

Market Cap
$945.15M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.69
Revenue (TTM)
$0.00
Return On Equity (TTM)
-141.62%
Profit Margin
N/A
Debt to Equity
0.28
Quarterly Earnings Growth YoY
-33.34%

Savara Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$32.24-$37.28-$40.23-$42.99
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-15.63%-7.91%-6.86%

Savara Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$38.15-$54.70-$95.88-$118.84
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-43.38%-75.28%-23.95%

Savara Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets11.8210.7411.6210.82
Current Assets241.62202.14165.95128.95
Total Assets253.44212.88177.56139.78
Non Current Liabilities29.9126.7126.626.13
Current Liabilities20.414.7210.65.87
Total Liabilities50.341.4337.1932.0
Shareholders' Equity203.13171.45140.37107.78

Savara Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-101.04-89.09-51.06-34.55
Investing-18.44-39.94-57.1252.65
Financing137.81117.5882.780.09

About Savara

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Savara Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.86
$4.29
-11.19%
Oct 2026
$5.14
$4.83
-6.67%
Sep 2026
$5.33
$5.17
-5.91%
Aug 2026
$5.40
$5.50
+0.73%
Jul 2026
$6.13
$5.46
-11.80%
Jun 2026
$5.13
$6.18
+18.94%
May 2026
$5.20
$5.20
-0.57%
Apr 2026
$5.51
$5.23
-4.30%
Mar 2026
$6.00
$5.46
-9.22%
Feb 2026
$5.34
$6.02
+11.58%
Jan 2026
$5.97
$5.39
-10.46%
Dec 2025
$5.93
$6.03
-4.06%

Savara Share Price FAQs